Search results

Order by most recent / most popular / relevance

Results: 1-10 of 13

FDA seeks public comment on questions related to drug and biological product shortages

Fox Rothschild LLP
-
USA
-
February 13 2013

Pursuant to the Food and Drug Administration Safety and Innovation Act (FDASIA) signed into law on July 9, 2012, the Food and Drug Administration

State's "more stringent" Stark Law restrictions upheld by court

Fox Rothschild LLP
-
USA
-
January 30 2013

Today I am focusing on the self-referral ban under the federal Stark laws. In particular, a recent case - Fresenius Medical Care Holdings, Inc. v

OIG announces 2013 priorities

Fox Rothschild LLP
-
USA
-
January 3 2013

Now that the new year is upon us, today's post will look at the Department of Health and Human Services' Office of Inspector General (OIG), in particular

Government suggests drug coupons do not violate the anti-kickback law

Fox Rothschild LLP
-
USA
-
October 2 2012

Today, I was intrigued by a Washington Post article about branded drug companies offering discount coupons to stave off competition from generic drug manufacturers

Bad actors continue to pay

Fox Rothschild LLP
-
USA
-
August 8 2012

Recent press releases provide notice of activities that draw the government's ire -- and result in serious criminal consequences

Court ruling broadens hospital exposure to whistleblower claims for teaching physician Medicare billing

Fox Rothschild LLP
-
USA
-
June 14 2012

The 7th Circuit Court of Appeals recently issued a decision of interest to physicians and teaching hospitals. It concerns the method of rotating teaching physicians between multiple surgeries and billing Medicare for those services

OIG alert encourages physicians to use care when reassigning Medicare payments

Fox Rothschild LLP
-
USA
-
April 9 2012

Physicians who reassign their right to bill the Medicare program can still be liable for false claims submitted by the entities who obtained that reassignment, as discussed in a recent "Alert" issued by the Office of Inspector General (OIG

Will the threat of personal liability stifle corporate activity?

Fox Rothschild LLP
-
USA
-
April 2 2012

Both the federal Food and Drug Administration (FDA) and Office of the Inspector General (OIG) have authority to seek personal consequences against corporate officers deemed responsible for federal health care violations

Physicians forewarned - the impact of medical device fraud on physicians' practices

Fox Rothschild LLP
-
USA
-
February 3 2012

A recent U.S. Department of Justice (DOJ) settlement with a medical device manufacturer highlights the need for physicians to pay close attention to their dealings with medical device companies

Federal prosecutors continue focus on health care fraud

Fox Rothschild LLP
-
USA
-
December 1 2011

Federal prosecutors continue to focus their efforts on preventing health care fraud, as evidenced by a recent case arising in Texas

next >